2003
DOI: 10.1021/jm020446l
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of 2-Phenylaminoimidazo[4,5-h]isoquinolin-9-ones:  Orally Active Inhibitors of lck Kinase

Abstract: The tyrosine kinase p56lck (lck) is essential for T cell activation; thus, inhibitors of lck have potential utility as autoimmune agents. Our initial disclosure of a new class of lck inhibitors based on the phenylaminoimidazoisoquinolin-9-one showed reasonable cellular activity but did not work in vivo upon oral administration. Our current work highlights the further use of rational drug design and molecular modeling to produce a series of lck inhibitors that demonstrate cellular activity below 100 nM and are … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(21 citation statements)
references
References 21 publications
(68 reference statements)
1
20
0
Order By: Relevance
“…Noteworthy, treatment with a selective Lck inhibitor 76 led to a significantly greater decrease in mean intensity levels of phospho‐Cas‐L than treatment with the selective ZAP70 inhibitor piceatannol, 74 suggesting that Cas‐L phosphorylation depends on Lck activity (Figures 2d and e).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Noteworthy, treatment with a selective Lck inhibitor 76 led to a significantly greater decrease in mean intensity levels of phospho‐Cas‐L than treatment with the selective ZAP70 inhibitor piceatannol, 74 suggesting that Cas‐L phosphorylation depends on Lck activity (Figures 2d and e).…”
Section: Resultsmentioning
confidence: 99%
“…The Src‐family kinase inhibitor PP2 73 was added to 1 × 10 6 cells in 100 μl at a final concentration of 10 μ m , incubated for 15 min at 37 °C, and added to the bilayers. Treatments with Lck inhibitor (10 μ m 76 ), Lck and Syk‐family inhibitor Piceatannol (10 μ m 74 ), PKCθ inhibitor C20 (10 μ m or 33 μ m 72 ), Arp2/3 inhibitor CK666 (10 μ m ), and actin polymerization inhibitor cytochalasin D (60 n m or 200 n m ) followed similar protocol described for PP2. All inhibitors were dissolved in DMSO, and all pharmacological experiments performed included a DMSO only incubation control.…”
Section: Methodsmentioning
confidence: 99%
“…Thus, small molecule inhibitors are attractive because they usually function within seconds and often do not require any other cell manipulation. Selective inhibitors of several TCR proximal cytoplasmic kinases such as Lck have been reported ( 15 ). Yet, despite much interest, no selective cell-permeable ZAP-70 inhibitors, other than a peptide inhibitor, have been reported, suggesting that this kinase presents a significant challenge to inhibitor development ( 16 ).…”
mentioning
confidence: 99%
“…To perform pharmacophore modeling calculations a dataset of 85 known inhibitors of Btk with diverse scaffold collected from different literature resources [ 26 29 ] and classified into two different data sets: (i) a training set and (ii) a test set. Training set was used to generate the hypothesis while the generated hypothesis was validated by a test set.…”
Section: Methodsmentioning
confidence: 99%